These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35462789)

  • 1. Vitronectin, a Novel Urinary Proteomic Biomarker, Promotes Cell Pyroptosis in Juvenile Systemic Lupus Erythematosus.
    Zhang S; Pan W; Wang H; Zhi C; Lin Y; Wu P; Ren Q; Wei P; Chen R; Li F; Xie Y; Wong CK; Tang H; Cai Z; Xu W; Zeng H
    Mediators Inflamm; 2022; 2022():8447675. PubMed ID: 35462789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis.
    Cai Z; Zhang S; Wu P; Ren Q; Wei P; Hong M; Feng Y; Wong CK; Tang H; Zeng H
    Clin Transl Med; 2021 Feb; 11(2):e309. PubMed ID: 33634995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of NLRP3 Single Nucleotide Polymorphisms in Juvenile Systemic Lupus Erythematosus (JSLE).
    Yazdanpanah N; Rezaei A; Ziaee V; Rezaei N
    Immunol Invest; 2023 Nov; 52(5):598-615. PubMed ID: 37262326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Hassan W; Behiry E; Mahgoub M
    Arch Rheumatol; 2021 Mar; 36(1):47-55. PubMed ID: 34046568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hsa_circ_0008945 in juvenile-onset systemic lupus erythematosus.
    Wang Q; Xu B; Zhang Q; Wang H; Chen S; Chen T; Liang S
    BMC Med Genomics; 2023 May; 16(1):97. PubMed ID: 37161408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococcus Faecalis activates NLRP3 inflammasomes leading to increased interleukin-1 beta secretion and pyroptosis of THP-1 macrophages.
    Ran S; Huang J; Liu B; Gu S; Jiang W; Liang J
    Microb Pathog; 2021 May; 154():104761. PubMed ID: 33524566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
    Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
    Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus.
    Yamada J; Peracchi OA; Terreri MT; de Moraes-Pinto MI
    Lupus; 2022 Sep; 31(10):1237-1244. PubMed ID: 35849633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus.
    Watson L; Midgley A; Pilkington C; Tullus K; Marks S; Holt R; Jones C; Beresford M
    Lupus; 2012 Apr; 21(5):496-501. PubMed ID: 22147846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
    Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
    Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA).
    Stagi S; Cavalli L; Bertini F; Signorini C; Matucci Cerinic M; de Martino M; Brandi ML; Falcini F
    Lupus; 2014 Nov; 23(13):1392-406. PubMed ID: 25074873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
    Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients.
    Eissa E; Kandil R; Dorgham D; Ghorab R; Kholoussi N
    Pediatr Rheumatol Online J; 2024 Jan; 22(1):20. PubMed ID: 38243322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance and clinical associations of antibodies to the chromatin antigenic system in juvenile systemic lupus erythematosus.
    Keusseyan SP; da Silva NP; Hilário MO; Okuda EM; Terreri MT; Andrade LE
    Rev Bras Reumatol; 2012 Oct; 52(5):695-712. PubMed ID: 23090370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome polymorphisms in juvenile systemic lupus erythematosus.
    Pontillo A; Reis EC; Liphaus BL; Silva CA; Carneiro-Sampaio M
    Autoimmunity; 2015; 48(7):434-7. PubMed ID: 26182076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS.
    Stagi S; Cavalli L; Bertini F; Matucci Cerinic M; Luisa Brandi M; Falcini F
    Lupus; 2014; 23(1):57-68. PubMed ID: 24218395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
    Lei Q; Yi T; Chen C
    Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-223-3p Regulates Pyroptosis Through NLRP3-Caspase 1-GSDMD Signal Axis in Periodontitis.
    Xia Y; Zhou K; Sun M; Shu R; Qian J; Xie Y
    Inflammation; 2021 Dec; 44(6):2531-2542. PubMed ID: 34637033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.